103 related articles for article (PubMed ID: 2316512)
1. Effects of 2'-deoxycoformycin on HL-60 cell differentiation, adenosine deaminase, and oligoadenylate synthetase.
Triozzi PL; Vicstein F
Am J Hematol; 1990 Apr; 33(4):274-6. PubMed ID: 2316512
[TBL] [Abstract][Full Text] [Related]
2. Combined effects of interferon and 2'-deoxycoformycin on 2',5'-oligoadenylate synthetase and adenosine deaminase in hairy cell and chronic lymphocytic leukemia cells.
Triozzi PL; Avery KA; Grever MR; Kraut EH
J Interferon Res; 1990 Oct; 10(5):535-40. PubMed ID: 2273300
[TBL] [Abstract][Full Text] [Related]
3. 2'-Deoxycoformycin inhibition of adenosine deaminase in rat brain: in vivo and in vitro analysis of specificity, potency, and enzyme recovery.
Padua R; Geiger JD; Dambock S; Nagy JI
J Neurochem; 1990 Apr; 54(4):1169-78. PubMed ID: 2179470
[TBL] [Abstract][Full Text] [Related]
4. Increase in 2',5'-oligoadenylate synthetase caused by deoxycoformycin in hairy cell leukaemia.
Ganeshaguru K; de Mel WC; Sissolak G; Catovsky D; Dearden CE; Mehta AB; Hoffbrand AV
Br J Haematol; 1992 Feb; 80(2):194-8. PubMed ID: 1550776
[TBL] [Abstract][Full Text] [Related]
5. Opposite effects of recombinant interferon-alpha A and deoxycoformycin on adenosine deaminase activity in the Daudi B lymphoblastoid cell line.
Faltynek CR
Blood; 1988 Jan; 71(1):59-64. PubMed ID: 3257147
[TBL] [Abstract][Full Text] [Related]
6. Neurotoxicity of deoxycoformycin: effect of constant infusion on adenosine deaminase, adenosine, 2'-deoxyadenosine and monoamines in the mouse brain.
Helland S; Broch OJ; Ueland PM
Neuropharmacology; 1983 Jul; 22(7):915-7. PubMed ID: 6604884
[TBL] [Abstract][Full Text] [Related]
7. Effects of adenosine deaminase inhibition on active uptake and metabolism of adenosine in astrocytes in primary cultures.
Matz H; Hertz L
Brain Res; 1990 May; 515(1-2):168-72. PubMed ID: 2357554
[TBL] [Abstract][Full Text] [Related]
8. Induction of differentiation of human myeloid leukemia cells by 2'-deoxycoformycin in combination with 2'-deoxyadenosine.
Niitsu N; Umeda M; Honma Y
Biochem Biophys Res Commun; 1997 Sep; 238(1):100-6. PubMed ID: 9299460
[TBL] [Abstract][Full Text] [Related]
9. Subcellular distribution of 2',5'-oligoadenylate synthetase in differentiating Friend leukemia cells.
Mechti N; Affabris E; Romeo G; Lebleu B
Differentiation; 1985; 29(2):136-9. PubMed ID: 2412925
[TBL] [Abstract][Full Text] [Related]
10. Activation of 2',5'-oligoadenylate synthetase activity on induction of HL-60 leukemia cell differentiation.
Schwartz EL; Nilson LA
Mol Cell Biol; 1989 Sep; 9(9):3897-903. PubMed ID: 2476665
[TBL] [Abstract][Full Text] [Related]
11. N6-cyclopropyl-PMEDAP: a novel derivative of 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) with distinct metabolic, antiproliferative, and differentiation-inducing properties.
Hatse S; Naesens L; De Clercq E; Balzarini J
Biochem Pharmacol; 1999 Jul; 58(2):311-23. PubMed ID: 10423173
[TBL] [Abstract][Full Text] [Related]
12. Inhibitor of 2', 5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon.
Heike T; Katamura K; Kubota M; Shinomiya K; Mikawa H
Adv Exp Med Biol; 1986; 195 Pt B():683-7. PubMed ID: 3490130
[No Abstract] [Full Text] [Related]
13. Rat brain adenosine deaminase after 2'-deoxycoformycin administration: biochemical properties and evidence for reduced enzyme levels detected by 2'-[3H]deoxycoformycin ligand binding.
Padua RA; Geiger JD; Delaney SM; Nagy JI
J Neurochem; 1992 Feb; 58(2):421-9. PubMed ID: 1729390
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor of 2',5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon.
Heike T; Katamura K; Kubota M; Shinomiya K; Mikawa H
Biochem Biophys Res Commun; 1985 Mar; 127(3):1019-25. PubMed ID: 3872657
[TBL] [Abstract][Full Text] [Related]
15. Ectopic expression of 2-5A synthetase in myeloid cells induces growth arrest and facilitates the appearance of a myeloid differentiation marker.
Salzberg S; Hyman T; Turm H; Kinar Y; Schwartz Y; Nir U; Lejbkowicz F; Huberman E
Cancer Res; 1997 Jul; 57(13):2732-40. PubMed ID: 9205084
[TBL] [Abstract][Full Text] [Related]
16. Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes.
Ratech H; Kim J; Asofsky R; Thorbecke GJ; Hirschhorn R
J Immunol; 1984 Jun; 132(6):3077-84. PubMed ID: 6202772
[TBL] [Abstract][Full Text] [Related]
17. Biochemical changes induced in hairy-cell leukemia following treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
Johnston JB; Begleiter A; Pugh L; Leith MK; Wilkins JA; Cavers DJ; Israels LG
Cancer Res; 1986 Apr; 46(4 Pt 2):2179-84. PubMed ID: 2418965
[TBL] [Abstract][Full Text] [Related]
18. Deoxycoformycin antagonizes ischemia-induced neuronal degeneration.
Phillis JW; O'Regan MH
Brain Res Bull; 1989 Mar; 22(3):537-40. PubMed ID: 2785431
[TBL] [Abstract][Full Text] [Related]
19. Clinical, pharmacologic, and immunologic effects of 2'-deoxycoformycin.
Cummings FJ; Crabtree GW; Wiemann MC; Spremulli EN; Parks RE; Calabresi P
Clin Pharmacol Ther; 1988 Nov; 44(5):501-9. PubMed ID: 3263248
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous epimerization of (S)-deoxycoformycin and interaction of (R)-deoxycoformycin, (S)-deoxycoformycin, and 8-ketodeoxycoformycin with adenosine deaminase.
Schramm VL; Baker DC
Biochemistry; 1985 Jan; 24(3):641-6. PubMed ID: 3873254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]